← Leaderboards
Peter Lobel
Univ Of Med/Dent Nj-R W Johnson Med Sch
$16,507,235
Attributed
$16,507,235
Total exposure
17
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$19,893,589 · 20
By mechanism
R01$10,868,100 · 3
P30$4,920,904 · 2
S10$3,667,335 · 14
R21$437,250 · 1
Top collaborators
- Hong Li4 shared
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsAlzheimer&AposProteomicsBaseS DiseaseLysosomesMass Spectrum AnalysisNeurodegenerative DisordersFutureAffectLaboratoriesEnzymesCessation Of LifeMolecularCommunitiesPeptide HydrolasesMolecular PathologyBrainDesignGeneticEffective TherapyMannose 6 PhosphateChildMouse Model
Grant awards (62)
Novel Lysosomal Enzyme Deficient in Batten Disease$497,259
R01 · FY2021 · NS · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$494,355
R01 · FY2020 · NS · contact PI
Evaluation of the lysosomal protease tripeptidyl peptidase 1 as a potential therapeutic for Alzheimer Disease$238,500
R21 · FY2020 · AG · contact PI
An Orbitrap Tribrid mass spectrometer and nanoflow LC system to upgrade the proteomics facility at Rutgers-New Brunswick and Robert Wood Johnson Medical School$921,333
S10 · FY2019 · OD · contact PI
Evaluation of the lysosomal protease tripeptidyl peptidase 1 as a potential therapeutic for Alzheimer Disease$198,750
R21 · FY2019 · AG · contact PI
Rutgers Mass Spectrometry Center for Integrative Neuroscience Research$636,000
P30 · FY2018 · NS
Rutgers Mass Spectrometry Core for Integrative Neuroscience Research$594,226
P30 · FY2018 · NS · contact PI
Rutgers Mass Spectrometry Center for Integrative Neuroscience Research$636,000
P30 · FY2017 · NS
Rutgers Mass Spectrometry Core for Integrative Neuroscience Research$594,226
P30 · FY2017 · NS · contact PI
Rutgers Mass Spectrometry Center for Integrative Neuroscience Research$636,000
P30 · FY2016 · NS
Rutgers Mass Spectrometry Core for Integrative Neuroscience Research$594,226
P30 · FY2016 · NS · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$313,031
R01 · FY2016 · NS · contact PI
Rutgers Mass Spectrometry Center for Integrative Neuroscience Research$636,000
P30 · FY2015 · NS
Rutgers Mass Spectrometry Core for Integrative Neuroscience Research$594,226
P30 · FY2015 · NS · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$347,813
R01 · FY2015 · NS · contact PI
A Mass Spectrometry System for Quantitative Proteomics$561,294
S10 · FY2014 · OD · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$344,335
R01 · FY2014 · NS · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$204,408
R01 · FY2013 · NS · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$130,000
R01 · FY2013 · NS · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$345,625
R01 · FY2012 · NS · contact PI
Lysosomal Enzymes and Associated Human Genetic Diseases$325,385
R01 · FY2012 · DK · contact PI
Lysosomal Enzymes and Associated Human Genetic Diseases$56,854
R01 · FY2012 · DK · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$22,192
R01 · FY2012 · NS · contact PI
Lysosomal Enzymes and Associated Human Genetic Diseases$382,239
R01 · FY2011 · DK · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$429,000
R01 · FY2010 · NS · contact PI
Lysosomal Enzymes and Associated Human Genetic Diseases$386,100
R01 · FY2010 · DK · contact PI
Lysosomal Enzymes and Associated Human Genetic Diseases$93,247
R01 · FY2010 · DK · contact PI
High Resolution LC-MS/MS System$500,000
S10 · FY2009 · RR · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$429,000
R01 · FY2009 · NS · contact PI
Lysosomal Enzymes and Associated Human Genetic Diseases$390,000
R01 · FY2009 · DK · contact PI
Lysosomal Enzymes and Associated Human Genetic Diseases$390,000
R01 · FY2008 · DK · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$350,175
R01 · FY2007 · NS · contact PI
Lysosomal Enzymes and Associated Human Genetic Diseases$379,609
R01 · FY2006 · DK · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$360,634
R01 · FY2006 · NS · contact PI
MALDI TOF TOF mass spectrometer$500,000
S10 · FY2005 · RR
Lysosomal Enzymes and Associated Human Genetic Diseases$387,228
R01 · FY2005 · DK
Novel Lysosomal Enzyme Deficient in Batten Disease$369,313
R01 · FY2005 · NS
MALDI TOF TOF MASS SPECTROMETER: CELL BIOLOGY$175,000
S10 · FY2005 · RR
MALDI TOF TOF MASS SPECTROMETER: CANCER$150,000
S10 · FY2005 · RR
MALDI TOF TOF MASS SPECTROMETER: GENETICS$150,000
S10 · FY2005 · RR
Novel Lysosomal Enzyme Deficient in Batten Disease$30,000
R01 · FY2005 · NS
MALDI TOF TOF MASS SPECTROMETER: AIDS$25,000
S10 · FY2005 · RR
Novel Lysosomal Enzyme Deficient in Batten Disease$369,313
R01 · FY2004 · NS
Tandem mass spectrometer$342,354
S10 · FY2004 · RR
Lysosomal Enzymes and Associated Human Genetic Diseases$326,375
R01 · FY2004 · DK
PROTEIN: STRUCTURE, FOLDING AND FUNCTION$82,165
S10 · FY2004 · RR
NOVEL LYSOSOMAL ENZYMES &ASSOCIATED HUMAN GENETIC DIS: BATTEN, LINCL, CONCL, NP$82,165
S10 · FY2004 · RR
GENES, GENOMICS &GENE THERAPY$82,165
S10 · FY2004 · RR
CANCER: BREAST, ONCOGENES$82,165
S10 · FY2004 · RR
Lysosomal Enzymes and Associated Human Genetic Diseases$32,267
R01 · FY2004 · DK
TANDEM MASS SPECTROMETER: STRUCTURE OF HIV REVERSE TRANSCRIPTASE WITH SUBSTRATES$13,694
S10 · FY2004 · RR
Lysosomal Enzymes and Associated Human Genetic Diseases$373,180
R01 · FY2003 · DK
Novel Lysosomal Enzyme Deficient in Batten Disease$369,313
R01 · FY2003 · NS
NOVEL LYSOSOMAL ENZYME DEFICIENT IN BATTEN DISEASE$275,073
R01 · FY2002 · NS
LYSOSOMAL ENZYMES AND ASSOCIATED HUMAN GENETIC DISEASES$262,514
R01 · FY2002 · DK
NOVEL LYSOSOMAL ENZYME DEFICIENT IN BATTEN DISEASE$267,061
R01 · FY2001 · NS
LYSOSOMAL ENZYMES AND ASSOCIATED HUMAN GENETIC DISEASES$254,867
R01 · FY2001 · DK
MOLECULAR BASIS OF LYSOSOMAL ENZYME TARGETING$273,612
R01 · FY2000 · DK
NOVEL LYSOSOMAL ENZYME DEFICIENT IN BATTEN DISEASE$259,281
R01 · FY2000 · NS
LYSOSOMAL ENZYMES AND ASSOCIATED HUMAN GENETIC DISEASES$247,442
R01 · FY2000 · DK
NOVEL LYSOSOMAL ENZYME DEFICIENT IN BATTEN DISEASE$50,000
R01 · FY2000 · NS
NOVEL LYSOSOMAL ENZYME DEFICIENT IN BATTEN DISEASE$50,000
R01 · FY2000 · NS